{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:02:39Z","timestamp":1787580159242,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Assessment of cancer patients\u00b4 quality of life (QoL) through patient-reported outcomes (PRO) during and after treatment is gaining ground. The HM-PRO is the first generic Haematological Malignancy specific PRO measure for use in clinical practice and clinical trials. Such generic tools are needed in Denmark. The study aim was to translate and cross-culturally adapt the HM-PRO into Danish and evaluate the psychometric properties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Translation and cross-cultural adaptation of the original English HM-PRO into Danish followed established guidelines. After cognitive debriefing interviews, it underwent psychometric testing with a variety of hematologic malignancies. Construct validity, internal consistency, dimensionality, item response theory (IRT) and differential item functioning were investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>295 patients were included for psychometric evaluation; confirmatory factor and bifactor analyses for both HM-PRO parts provided good evidence to support the suggested factor structure (Cronbach\u2019s-\u03b1 Part-A\u2009=\u20090.81, Part-B\u2009=\u20090.84; Part-A CFA CFI\u2009=\u20090.922, TLI\u2009=\u20090.912; bi-factor CFI\u2009=\u20090.989, TLI\u2009=\u20090.978). IRT showed good item-fit and factor loadings and absence of local dependency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The HM-PRO has demonstrated favourable psychometric properties and can be used broadly within the Danish Healthcare system to monitor symptoms as well as QoL impact of patients with haematological cancer and optimize patient engagement during routine cancer care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>What is the new aspect of your work?<\/jats:title>\n                    <jats:p>In response to the intention of the Danish Health Authority to systematically collect PRO data on health-related QoL in Danish cancer patients, this study investigates the translation and cross-cultural adaptation of the original English HM-PRO into Danish.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>What is the central finding of your work?<\/jats:title>\n                    <jats:p>Few issues were met with the translation and adaptation of HM-PRO into Danish.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>What is (or could be) the specific clinical relevance of your work?<\/jats:title>\n                    <jats:p>The HM-PRO has demonstrated favourable psychometric properties and can be used broadly within the Danish Healthcare system to monitor symptoms as well as QoL impact of patients with haematological cancer and optimize patient engagement during routine cancer care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41687-025-00869-2","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:30:10Z","timestamp":1745901010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Translation, cultural adaptation and validation of the Danish version of the haematological malignancy patient-reported outcome measure (HM-PRO)"],"prefix":"10.1186","volume":"9","author":[{"given":"Sam","family":"Salek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Abildgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Torp","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Asdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper Kofod","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Therese","family":"Lassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christen Lykkegaard","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene Kongsgaard","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"7","key":"869_CR1","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1182\/blood-2017-03-737403","volume":"130","author":"F Efficace","year":"2017","unstructured":"Efficace F, Gaidano G, Lo-Coco F (2017) Patient-reported outcomes in hematology: Is it time to focus more on them in clinical trials and hematology practice? Blood 130(7):859\u2013866","journal-title":"Blood"},{"issue":"14","key":"869_CR2","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.ejca.2005.04.041","volume":"41","author":"A Bredart","year":"2005","unstructured":"Bredart A, Bottomley A, Blazeby JM, Conroy T, Coens C, D\u2019Haese S et al (2005) An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32). Eur J Cancer 41(14):2120\u20132131","journal-title":"Eur J Cancer"},{"issue":"8","key":"869_CR3","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s11136-011-0054-x","volume":"21","author":"CF Snyder","year":"2012","unstructured":"Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY et al (2012) Implementing patient-reported outcomes assessment in clinical practice: A review of the options and considerations. Qual Life Res 21(8):1305\u20131314","journal-title":"Qual Life Res"},{"issue":"5","key":"869_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365\u2013376","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"869_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ejh.12882","volume":"99","author":"LK Nielsen","year":"2017","unstructured":"Nielsen LK, Jarden M, Andersen CL, Frederiksen H, Abildgaard N (2017) A systematic review of health-related quality of life in longitudinal studies of myeloma patients. Eur J Haematol 99(1):3\u201317","journal-title":"Eur J Haematol"},{"issue":"4","key":"869_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/ejh.13203","volume":"102","author":"P Goswami","year":"2019","unstructured":"Goswami P, Khatib Y, Salek S (2019) Haematological malignancy: Are we measuring what is important to patients? A systematic review of quality-of-life instruments. Eur J Haematol 102(4):279\u2013311","journal-title":"Eur J Haematol"},{"issue":"7","key":"869_CR7","doi-asserted-by":"publisher","first-page":"A709","DOI":"10.1016\/j.jval.2015.09.2668","volume":"18","author":"S Salek","year":"2015","unstructured":"Salek S, Kamudoni P, Oliva E, Ionova T (2015) Quality of life issues important to patients with haematological malignancies. Value Health 18(7):A709","journal-title":"Value Health"},{"key":"869_CR8","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.3389\/fphar.2020.01308","volume":"11","author":"P Goswami","year":"2020","unstructured":"Goswami P, Oliva EN, Ionova T, Else R, Kell J, Fielding AK et al (2020) Hematological malignancy specific Patient-Reported outcome measure (HM-PRO): Construct validity study. Front Pharmacol 11:1308","journal-title":"Front Pharmacol"},{"key":"869_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fphar.2020.00209","volume":"11","author":"P Goswami","year":"2020","unstructured":"Goswami P, Oliva EN, Ionova T, Else R, Kell J, Fielding AK et al (2020) Development of a novel hematological malignancy specific patient-reported outcome measure (HM-PRO): Content validity. Front Pharmacol 11:209","journal-title":"Front Pharmacol"},{"key":"869_CR10","unstructured":"Goswami P, Salek S, Ionova T, Oliva EN, Fielding AK, Karakantza M et al (2017) HM-PRO: A Novel Patient-Reported Outcome Measure in Hematological Malignancy for Use in Clinical Practice. Blood 130(Suppl 1):2176"},{"issue":"24","key":"869_CR11","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1097\/00007632-200012150-00014","volume":"25","author":"DE Beaton","year":"2000","unstructured":"Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 25(24):3186\u20133191","journal-title":"Spine (Phila Pa 1976)"},{"issue":"11","key":"869_CR12","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0895-4356(98)00082-1","volume":"51","author":"M Bullinger","year":"1998","unstructured":"Bullinger M, Alonso J, Apolone G, Leplege A, Sullivan M, Wood-Dauphinee S et al (1998) Translating health status questionnaires and evaluating their quality: The IQOLA project approach. International quality of life assessment. J Clin Epidemiol 51(11):913\u2013923","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"869_CR13","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/0895-4356(93)90142-N","volume":"46","author":"F Guillemin","year":"1993","unstructured":"Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines. J Clin Epidemiol 46(12):1417\u20131432","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"869_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1586\/erp.11.102","volume":"12","author":"M Koller","year":"2012","unstructured":"Koller M, Kantzer V, Mear I, Zarzar K, Martin M, Greimel E et al (2012) The process of reconciliation: Evaluation of guidelines for translating quality-of-life questionnaires. Expert Rev Pharmacoecon Outcomes Res 12(2):189\u2013197","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"869_CR15","volume-title":"WHO classification of tumours of Haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon"},{"issue":"6","key":"869_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3200\/JOER.99.6.323-338","volume":"99","author":"JB Schreiber","year":"2006","unstructured":"Schreiber JB, Nora A, Stage FK, Barlow EA, King J (2006) Reporting structural equation modeling and confirmatory factor analysis results: A review. J Educ Res 99(6):323\u2013338","journal-title":"J Educ Res"},{"key":"869_CR17","volume-title":"Psychometric theory","author":"JCBI Nunnally","year":"1994","unstructured":"Nunnally JCBI (1994) Psychometric theory. McGraw-Hill, New York"},{"key":"869_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780198527695.001.0001","volume-title":"Assessing quality of life in clinical trials: methods and practice","author":"PHR Fayers","year":"2005","unstructured":"Fayers PHR (2005) Assessing quality of life in clinical trials: Methods and practice. Oxford University Press, New York"},{"key":"869_CR19","unstructured":"Brown TA (2015) Confirmatory Factor Analysis for Applied Research Second Edition. Guilford Publications, New York"},{"key":"869_CR20","first-page":"205","volume-title":"Testing structural equation models","author":"BO Muth\u00e9n","year":"1993","unstructured":"Muth\u00e9n BO, Bollen KA, Long JS (1993) Goodness of fit with categorical and other non-normal variables. Testing structural equation models. A:Sage, Newbury Park, CA: Sage pp 205\u2013243"},{"issue":"2","key":"869_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF02289113","volume":"16","author":"LJ Cronbach","year":"1951","unstructured":"Cronbach LJ, Warrington WG (1951) Time-limit tests: Estimating their reliability and degree of speeding. Psychometrika 16(2):167\u2013188","journal-title":"Psychometrika"},{"issue":"4","key":"869_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1037\/h0040957","volume":"52","author":"LJ Cronbach","year":"1955","unstructured":"Cronbach LJ, Meehl PE (1955) Construct validity in psychological tests. Psychol Bull 52(4):281\u2013302","journal-title":"Psychol Bull"},{"key":"869_CR23","unstructured":"Goswami P (2019) The conceptualization, development and validation of a treatment-related patient-reported outcome measure in haematological malignancies for use in clinical practice. Thesis, University of Hertfordshire"},{"issue":"3","key":"869_CR24","first-page":"265","volume":"22","author":"W-H Chen","year":"1997","unstructured":"Chen W-H, Thissen D (1997) Local dependence indexes for item pairs using item response theory. JEBS 22(3):265\u2013289","journal-title":"JEBS"},{"key":"869_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5116\/ijme.4dfb.8dfd","volume":"2","author":"M Tavakol","year":"2011","unstructured":"Tavakol M, Dennick R (2011) Making sense of Cronbach\u2019s alpha. Int J Med Educ 2:53\u201355","journal-title":"Int J Med Educ"},{"key":"869_CR26","doi-asserted-by":"crossref","unstructured":"Sztankay M, Giesinger J, Holzner B (2011) Gender differences in quality of life in patients with haematological malignancies. MEMO: Magazine Eur Med Oncol. 224\u2013226","DOI":"10.1007\/s12254-011-0299-7"},{"issue":"2","key":"869_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1017\/S1478951513000849","volume":"13","author":"CD Bergerot","year":"2015","unstructured":"Bergerot CD, Clark KL, Nonino A, Waliany S, Buso MM, Loscalzo M (2015) Course of distress, anxiety, and depression in hematological cancer patients: Association between gender and grade of neoplasm. Palliat Support Care 13(2):115\u2013123","journal-title":"Palliat Support Care"},{"issue":"2","key":"869_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1526-4637.2008.00558.x","volume":"10","author":"CJ Paller","year":"2009","unstructured":"Paller CJ, Campbell CM, Edwards RR, Dobs AS (2009) Sex-based differences in pain perception and treatment. Pain Med 10(2):289\u2013299","journal-title":"Pain Med"},{"issue":"6","key":"869_CR29","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National comorbidity survey replication. Arch Gen Psychiatry 62(6):593\u2013602","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"869_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ejon.2010.12.005","volume":"15","author":"D Pud","year":"2011","unstructured":"Pud D (2011) Gender differences in predicting quality of life in cancer patients with pain. Eur J Oncol Nurs 15(5):486\u2013491","journal-title":"Eur J Oncol Nurs"},{"issue":"4","key":"869_CR31","doi-asserted-by":"publisher","first-page":"e13067","DOI":"10.1111\/ecc.13067","volume":"28","author":"A Immanuel","year":"2019","unstructured":"Immanuel A, Hunt J, McCarthy H, van Teijlingen E, Sheppard ZA (2019) Quality of life in survivors of adult haematological malignancy. Eur J Cancer Care (Engl) 28(4):e13067","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"2","key":"869_CR32","first-page":"117","volume":"66","author":"D Priscilla","year":"2011","unstructured":"Priscilla D, Hamidin A, Azhar MZ, Noorjan KO, Salmiah MS, Bahariah K (2011) Quality of life among patients with hematological cancer in a Malaysian hospital. Med J Malaysia 66(2):117\u2013120","journal-title":"Med J Malaysia"},{"key":"869_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S1507-1367(10)60062-4","volume":"12","author":"L Slovacek","year":"2007","unstructured":"Slovacek L, Slovackova B, Pavlik V, Jebavy L (2007) Health-related quality of life in acute myeloid leukaemia and multiple myeloma survivors undergoing autologous progenitor stem cell transplantation: A retrospective analysis. Rep Prac Oncol Radiother 12:231\u2013238","journal-title":"Rep Prac Oncol Radiother"},{"issue":"7","key":"869_CR34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2217\/cer-2018-0108","volume":"8","author":"P Goswami","year":"2019","unstructured":"Goswami P, Oliva EN, Ionova T, Else R, Kell J, Fielding AK et al (2019) Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: An equivalence study. J Comp Eff Res 8(7):523\u2013533","journal-title":"J Comp Eff Res"},{"issue":"6","key":"869_CR35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P et al (2016) Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial. J Clin Oncol 34(6):557\u2013565","journal-title":"J Clin Oncol"},{"issue":"6","key":"869_CR36","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/cncr.31193","volume":"124","author":"F Efficace","year":"2018","unstructured":"Efficace F, Cottone F, Abel G, Niscola P, Gaidano G, Bonnetain F et al (2018) Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes. Cancer 124(6):1251\u20131259","journal-title":"Cancer"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-025-00869-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-025-00869-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-025-00869-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:55:49Z","timestamp":1748408149000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-025-00869-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["869"],"URL":"https:\/\/doi.org\/10.1186\/s41687-025-00869-2","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For author Lene Kongsgaard Nielsen affiliation 5 was replace with affiliation 10.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to Danish law, this study was exempted for notification to the regulatory authorities. The study was approved by the Danish Data Protection Agency (Journal number 19\/13870).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the authors have given consent of publication of this manuscript in The Journal of Patient Reported Outcomes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SS is a joint copyright holder of the HM-PRO. LKN, TR, CLA, PA, MTL, SM, KKP, MTL, NA have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"43"}}